UBS Starts Chemed (CHE) at Buy

September 25, 2026 3:39 AM

UBS analyst AJ Rice initiates coverage on Chemed (NYSE: CHE) with a Buy rating and a price target of $650.00.The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found